Basmah has more than 11 years’ experience in the life science sector combining both consulting and academia. She joined Dolon from Ernst & Young where she was a member of the Business Design team. She has supported clients through various pricing & market access challenges across a range of therapeutic areas including oncology, cardiovascular and rare diseases. Basmah holds a PhD in Biotechnology and MPhil in Bioscience Enterprise from the University of Cambridge.
Featured
The Living Launch Plan: Keeping Pharma Launch Strategy Aligned
Discover how a living launch plan helps pharmaceutical teams adapt to evolving evidence, competitive dynamics, and changing market conditions.
News and insights
Featured
The New Drivers of Pharma Launch Uptake
Learn why precision in launch strategy is becoming essential for improving pharmaceutical launch uptake and commercial performance.
One-Size-Fits-All Launches Are Over
Read the article to discover why modern pharma launches require a precision approach, helping teams prioritize Must-Win Moments, reduce risk, and improve launch success.
ONWARD: Driving Equitable Access and System Readiness in Cancer Care
This Dolon Institute paper highlights six interconnected barriers affecting timely access to oncology innovation, drawing on examples from healthcare systems around the world.
Careers
Work with us
If you're looking to stretch your thinking, lead with purpose, and be part of a culture that values curiosity, accountability and trust, you're in the right place.
